Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Ovation Science's gross profit for the
three
months ended in Mar. 2026 was $0.01 Mil. Ovation Science's gross profit for the trailing twelve months (TTM) ended in Mar. 2026 was $0.04 Mil.
Gross Margin % is calculated as gross profit divided by its revenue. Ovation Science's gross profit for the
three
months ended in Mar. 2026 was $0.01 Mil. Ovation Science's Revenue for the
three
months ended in Mar. 2026 was $0.01 Mil. Therefore, Ovation Science's Gross Margin % for the quarter that ended in Mar. 2026 was N/A%.
Ovation Science had a gross margin of N/A% for the quarter that ended in Mar. 2026 => No sustainable competitive advantage
During the past 9 years, the highestGross Margin % of Ovation Science was 97.83%. The lowest was 73.07%. And the median was 85.36%.
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
Ovation Science had a gross margin of N/A% for the quarter that ended in Mar. 2026 => No sustainable competitive advantage
Ovation Science Gross Profit Related Terms
Ovation Science Gross Profit Historical Data
* Premium members only.
The historical data trend for Ovation Science's Gross Profit can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Ovation Science's Gross Profit, along with its competitors' market caps and Gross Profit data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Ovation Science Gross Profit vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Ovation Science's Gross Profit distribution charts can be found below:
* The bar in red indicates where Ovation Science's Gross Profit falls into.
Gross Profit for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.04 Mil.
Gross Profit is the numerator in the calculation of Gross Margin.
(Note that if there's no value for Cost of Goods Sold, then Gross Margin % is not calculated.)
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
Ovation Science (OVATF) has a Gross Profit of $0.04 Mil as of Mar. 2026. Gross Profit equals net sales less total cost of goods sold. View historical data on Ovation Science and its competitors.
Is Ovation Science's Gross Profit too high?
Ovation Science's current Gross Profit is $0.04 Mil.
How does Ovation Science's Gross Profit compare to ZTS and UTHR?
Ovation Science's Gross Profit of $0.04 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Profit for a Drug Manufacturers company?
A good Gross Profit depends on the Drug Manufacturers industry context. However, Gross Profit should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Profit mean?
A high Gross Profit can signal that a stock is expensive relative to its fundamentals. Gross Profit equals net sales less total cost of goods sold. View historical data on Ovation Science and its competitors. Ovation Science's current Gross Profit is $0.04 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ovation Science stock overvalued right now?
Ovation Science (OVATF) has a current Gross Profit of $0.04 Mil. The stock's GF Value™ is $0.04, compared to a current price of $0.04 — trading 12.5% below its estimated fair value. The current Gross Profit is $0.04 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Profit calculated?
Gross Profit is calculated from a company's financial statements. For Ovation Science (OVATF), the current Gross Profit is $0.04 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Ovation Science Inc. is a Canada-based company mainly engaged in the business of providing topical and transdermal cannabis products under the Ovation brand label, utilizing patented Invisicare delivery technology. The Company operates in one reportable operating segment, the sub-licensing and sales of cannabis products that utilize Invisicare, a patented polymer-based technology for topical and transdermal skin care products.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
OVATF has been successfully added to your 
